GSK

Gsk Plc-spon Adr

+$1.0B

Net Activity

Institutions Holding

1027

Popularity Rank

#425

Avg Weight

0.21%

Total Value

$20.8B

Ownership Trend

1027 institutions currently hold GSK, with 441 net buyers and 461 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

461

Net Buying Institutions

441

Key Holders

Key Holders

Top 5 by Value

FL
FMR LLC
$3.7B
D&
Dodge & Cox
$3.2B
FA
Fisher Asset Management, LLC
$1.9B
PM
Primecap Management Co/ca/
$1.4B
AA
Acadian Asset Management LLC
$651.0M

Top 5 by Conviction

JE
JTC Employer Solutions Trustee Ltd
41.69%
EP
Eversept Partners, LP
5.20%
CC
Callodine Capital Management, LP
4.86%
MI
Mondrian Investment Partners LTD
4.12%
EI
Equity Investment CORP
3.48%
View all 1027 holding institutions

Quarterly Activity

Recent Activity

+$11.7B

Total Buy Value

$10.8B

Total Sell Value

New buy124
Trim381
Add317
Sold out80

441

Net Buyers

461

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding GSK PLC-SPON ADR (GSK)?
Major stakeholders currently include FMR LLC ($3.7B), Dodge & Cox ($3.2B), Fisher Asset Management, LLC ($1.9B). Based on the latest 13F filings, there are a total of 1027 tracked investment funds and institutions maintaining positions in GSK.
What is the overall institutional sentiment toward GSK recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $1.0B, driven by 441 managers accumulating shares while 461 reduced their exposure.
Which institutions have been selling or reducing their GSK positions?
In the latest period, 381 funds trimmed their holdings, and 80 managers completely exited their positions. The aggregate reported sell value was $10.8B.
Are there any notable investors adding GSK to their portfolios?
Yes, buying activity remains notable. 124 institutions opened new positions in {ticker}, and 317 existing holders added to their shares. The total reported buy value for the quarter amounted to $11.7B.

Related Stocks

Same Sector

Other stocks in the same GICS sector

JNJ

Johnson & Johnson

Institutions Holding

4,603

Total reported value

$438.8B

961 institutions currently hold both GSK and this stock

View detail
LLY

Eli Lilly & Co

Institutions Holding

4,337

Total reported value

$730.5B

944 institutions currently hold both GSK and this stock

View detail
ABBV

Abbvie INC

Institutions Holding

4,024

Total reported value

$283.9B

930 institutions currently hold both GSK and this stock

View detail

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,150

Total reported value

$2.1T

3245 13F institutions increased their position this quarter

View detail
AMZN

Amazon.com INC

Institutions Holding

5,957

Total reported value

$1.5T

3028 13F institutions increased their position this quarter

View detail
NVDA

Nvidia CORP

Institutions Holding

5,764

Total reported value

$3.0T

2743 13F institutions increased their position this quarter

View detail